Healthcare utilization, mortality, and cardiovascular events following GLP1-RA initiation in chronic kidney disease
Folkerts, K. et al. Annual health care resource utilization and cost among type 2 diabetes patients with newly recognized chronic...
cardiovascular
Semaglutide Lowers Risk of Major Kidney Outcomes, Cardiovascular Events, Death in Patients With Diabetes and CKD
In patients with type 2 diabetes (T2D) and chronic kidney disease (CKD), semaglutide reduced the risk of clinically important kidney...
Sun Life partners with Somatus to provide comprehensive services for late-stage kidney disease and cardiovascular care
WELLESLEY, Mass., Feb. 6, 2024 /PRNewswire/ -- Sun Life U.S. has named Somatus as a preferred partner to further support...
